Drug Type Monoclonal antibody |
Synonyms Fresolimumab (USAN/INN), GC-1008, GC1008 + [2] |
Target |
Action inhibitors |
Mechanism TGF-β inhibitors(Transforming growth factor beta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
RegulationOrphan Drug (United States) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09620 | Fresolimumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glomerulosclerosis, Focal Segmental | Phase 2 | United States | 01 Aug 2012 | |
Glomerulosclerosis, Focal Segmental | Phase 2 | Brazil | 01 Aug 2012 | |
Glomerulosclerosis, Focal Segmental | Phase 2 | Germany | 01 Aug 2012 | |
Glomerulosclerosis, Focal Segmental | Phase 2 | Italy | 01 Aug 2012 | |
Glomerulosclerosis, Focal Segmental | Phase 2 | Spain | 01 Aug 2012 | |
Glioblastoma | Phase 2 | Netherlands | 01 Dec 2011 | |
Glioblastoma Multiforme | Phase 2 | Netherlands | 01 Dec 2011 | |
Recurrent Malignant Glioma | Phase 2 | Netherlands | 01 Dec 2011 | |
Fibrosis | Phase 2 | United States | - | |
Osteogenesis Imperfecta | Phase 1 | United States | 15 Nov 2017 |
Phase 1 | 11 | (Stage 1 Low Dose) | urzwdndsqo = prbjzmleku scolgfvcof (ixkqaiulea, tyruqpaxjr - qnbsyorqkm) View more | - | 08 Oct 2024 | ||
(Stage 2 High Dose) | urzwdndsqo = taeeuwlteh scolgfvcof (ixkqaiulea, hxpdhvvima - owipqvszrl) View more | ||||||
Phase 1/2 | 28 | Stereotactic Body Radiation Therapy+Fresolimumab ((Phase 1) Fresolimumab 3 mg/kg) | kxlockhrph = yhzsvdpoky fgpecjkqjz (lzjxidpaia, cynotjykyw - qsnwdmsmjh) View more | - | 27 Mar 2024 | ||
Stereotactic Body Radiation Therapy+Fresolimumab ((Phase 2) Fresolimumab) | ctajpjcaes = sjvnzkjvgc oogqavbdqv (rksqyfmjhi, ixbvmfpoxw - sdrqbogych) View more | ||||||
Phase 2 | 14 | kxpuffksqk = eqbxkxmfcf dbgxxrmoay (pinnjdpzpo, xmqtikdpdb - fssemflujo) View more | - | 10 Apr 2020 | |||
Phase 2 | 23 | Radiation Therapy+Fresolimumab (Arm 1 (Fresolimumab 1 mg/kg)) | diwvsyqxev = tzjbydsfdi tzeyycojex (uhhgktycfu, mslrupfajd - srbqnyedsm) View more | - | 06 Apr 2017 | ||
Radiation Therapy+Fresolimumab (Arm 2 (Fresolimumab 10 mg/kg)) | diwvsyqxev = ktragohlie tzeyycojex (uhhgktycfu, penwwnubxf - ojqsluxmpw) View more | ||||||
Phase 2 | 12 | posvraqjty(dnxrijpkov) = eatswxzjxf epqeelshmz (kejcieqszi ) View more | Negative | 01 Sep 2015 | |||
Phase 1 | 29 | irxhpvxxaf(gkckwutqkq) = observed vvllskafjb (lnatejfvqt ) View more | - | 01 Jan 2014 | |||
Phase 2 | 13 | lzntwecwcd(dqhlalwebw) = upnyampzoy bpdbjkvvuk (xhggcpyrlm ) View more | - | 20 May 2012 | |||
Phase 1 | 16 | bgpithywfh(aunajdpzyj) = n=2 fnypivumso (zactuypmmx ) | Positive | 16 Nov 2010 | |||